Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-4-5
|
pubmed:abstractText |
The effect of an eicosapentaenoic acid-rich encapsulated preparation of fish oil on the incidence of early restenosis after coronary angioplasty was assessed by a randomized double-blind placebo-controlled study. A total of 108 patients received either 10 capsules of fish oil (1.8 g eicosapentaenoic acid, 1.2 g docosahexaenoic acid) or 10 control capsules (50% olive oil, 50% corn oil), commencing the day before angioplasty and continuing for 4 months after angioplasty, in addition to treatment with aspirin and verapamil. In 101 (94%) of the 108 patients, follow-up angiographic or postmortem result was evaluated at a mean (+/- SD) of 100 (+/- 22) days. Angiographic restenosis was observed in 34% of patients (29% of lesions) in the fish oil-treated group and 33% of patients (31% of lesions) in the control group (no significant difference). The overall incidence of angiographic restenosis was significantly higher in patients with 1) recurrent angina pectoris, 2) a positive exercise test at follow-up after angioplasty, 3) residual stenosis greater than 30% immediately after angioplasty, and 4) dilation of the left anterior descending or right coronary artery. Biochemical investigations showed a greater decrease in the serum triglyceride levels in the fish oil-treated group versus the control group (p less than 0.05) but no differences between the two groups in cholesterol levels or platelet counts over the 4 month period. In conclusion, in this study, the administration of fish oil at a dose of 10 capsules/day did not reduce the incidence of early restenosis after coronary angioplasty.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Eicosapentaenoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Fish Oils
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0735-1097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
665-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2537349-Adult,
pubmed-meshheading:2537349-Angioplasty, Balloon,
pubmed-meshheading:2537349-Arachidonic Acid,
pubmed-meshheading:2537349-Arachidonic Acids,
pubmed-meshheading:2537349-Cholesterol,
pubmed-meshheading:2537349-Coronary Disease,
pubmed-meshheading:2537349-Double-Blind Method,
pubmed-meshheading:2537349-Eicosapentaenoic Acid,
pubmed-meshheading:2537349-Female,
pubmed-meshheading:2537349-Fish Oils,
pubmed-meshheading:2537349-Follow-Up Studies,
pubmed-meshheading:2537349-Humans,
pubmed-meshheading:2537349-Male,
pubmed-meshheading:2537349-Middle Aged,
pubmed-meshheading:2537349-Random Allocation,
pubmed-meshheading:2537349-Recurrence,
pubmed-meshheading:2537349-Risk Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty.
|
pubmed:affiliation |
Department of Cardiology, Royal Melbourne Hospital, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|